Author: Su, Yu-Jang; Chang, Chen-Wang; Chen, Ming-Jen; Lai, Yen-Chun
Title: Impact of COVID-19 on liver Cord-id: xbwng7yw Document date: 2021_9_26
ID: xbwng7yw
Snippet: The incidence of liver injury after coronavirus disease 2019 (COVID-19) infection ranged from 15%-53%. The mechanism includes direct viral cytopathic effect, cytokinesis, and treatment drug-induced liver injury. The symptoms include nausea, vomiting, diarrhea, and loss of appetite. The laboratory results include increased liver enzyme levels, decreased monocyte count, and longer prothrombin time. The most common imaging findings are hepatomegaly on ultrasound, ground-glass opacity on chest compu
Document: The incidence of liver injury after coronavirus disease 2019 (COVID-19) infection ranged from 15%-53%. The mechanism includes direct viral cytopathic effect, cytokinesis, and treatment drug-induced liver injury. The symptoms include nausea, vomiting, diarrhea, and loss of appetite. The laboratory results include increased liver enzyme levels, decreased monocyte count, and longer prothrombin time. The most common imaging findings are hepatomegaly on ultrasound, ground-glass opacity on chest computed tomography (CT), and liver hypodensity and pericholecystic fat stranding on abdominal CT. Patients may also have different presentations and poor outcomes of different liver diseases concomitant with COVID-19 infection. Liver function test (LFT) results should be monitored, and all factors known to cause or predispose liver injury should be investigated while managing the patients. The risks of transfer to an intensive care unit, need for mechanical ventilator support, and acute kidney injury is higher in COVID-19 patients with than without abnormal LFTs. Increased mortality and length of hospital stay are both observed.
Search related documents:
Co phrase search for related documents- abdominal pain and acute aki kidney injury: 1, 2, 3, 4, 5, 6
- abdominal pain and acute hepatitis: 1, 2, 3, 4, 5, 6
- abdominal pain and acute liver injury: 1, 2, 3, 4, 5
- abdominal pain and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- abdominal pain and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal lft and acute sars cov respiratory syndrome coronavirus: 1
- abnormal liver function and acute aki kidney injury: 1
- abnormal liver function and acute hepatitis: 1, 2
- abnormal liver function and acute liver injury: 1, 2, 3, 4, 5, 6
- abnormal liver function and acute respiratory distress syndrome: 1
- abnormal liver function and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- abnormal liver function test and acute liver injury: 1
- abnormal liver function test and acute sars cov respiratory syndrome coronavirus: 1, 2
- abnormal liver test and acute liver injury: 1
- abnormal liver test and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
- acute aki kidney injury and additional evidence: 1
- acute hepatitis and additional evidence: 1
- acute respiratory distress syndrome and additional evidence: 1, 2, 3, 4, 5, 6, 7
- acute sars cov respiratory syndrome coronavirus and liver cholangiocyte: 1
Co phrase search for related documents, hyperlinks ordered by date